This is highly significant because FF is safe and currently used in the clinic, and the identification of these mechanisms should significantly accelerate its adoption for the prevention of DN in diabetic patients.
← all excerpts
The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy.
1
—
—